These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23830962)

  • 21. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
    Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
    J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jaws.
    Treister NS; Richardson P; Schlossman R; Miller K; Woo SB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun; 105(6):e1-4. PubMed ID: 18417376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up.
    Vescovi P; Manfredi M; Merigo E; Guidotti R; Meleti M; Pedrazzi G; Fornaini C; Bonanini M; Ferri T; Nammour S
    Photomed Laser Surg; 2012 Jan; 30(1):5-13. PubMed ID: 22054203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?
    Mawardi H; Treister N; Richardson P; Anderson K; Munshi N; Faiella RA; Woo SB
    J Oral Maxillofac Surg; 2009 Mar; 67(3):593-601. PubMed ID: 19231786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of bisphosphonate-related osteonecrosis of the jaw: a literature review.
    Spanou A; Lyritis GP; Chronopoulos E; Tournis S
    Oral Dis; 2015 Nov; 21(8):927-36. PubMed ID: 25732104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.
    Otto S; Schreyer C; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum S; Pautke C
    J Craniomaxillofac Surg; 2012 Jun; 40(4):303-9. PubMed ID: 21676622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) patients with sitafloxacin: new strategies for the treatment of BRONJ.
    Ikeda T; Kuraguchi J; Kogashiwa Y; Yokoi H; Satomi T; Kohno N
    Bone; 2015 Apr; 73():217-22. PubMed ID: 25549869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review.
    Weber JB; Camilotti RS; Ponte ME
    Lasers Med Sci; 2016 Aug; 31(6):1261-72. PubMed ID: 27025860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
    Shintani T; Hayashido Y; Mukasa H; Akagi E; Hoshino M; Ishida Y; Hamana T; Okamoto K; Kanda T; Koizumi K; Yoshioka Y; Tani R; Toratani S; Okamoto T
    Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Observational study of the bisphosphonate-related osteonecrosis of jaws.
    Lungu AE; Lazar MA; Tonea A; Rotaru H; Roman RC; Badea ME
    Clujul Med; 2018; 91(2):209-215. PubMed ID: 29785160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
    Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.
    Martins MA; Martins MD; Lascala CA; Curi MM; Migliorati CA; Tenis CA; Marques MM
    Oral Oncol; 2012 Jan; 48(1):79-84. PubMed ID: 21940198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.
    Stanton DC; Balasanian E
    J Oral Maxillofac Surg; 2009 May; 67(5):943-50. PubMed ID: 19375001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resource utilization in cancer patients with bisphosphonate-associated osteonecrosis of the jaw.
    Najm MS; Solomon DH; Woo SB; Treister NS
    Oral Dis; 2014 Jan; 20(1):94-9. PubMed ID: 23419136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
    López-Cedrún JL; Sanromán JF; García A; Peñarrocha M; Feijoo JF; Limeres J; Diz P
    Br J Oral Maxillofac Surg; 2013 Dec; 51(8):874-9. PubMed ID: 23866309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
    Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
    Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course and therapeutic outcomes of operatively and non-operatively managed patients with denosumab-related osteonecrosis of the jaw (DRONJ).
    Hoefert S; Yuan A; Munz A; Grimm M; Elayouti A; Reinert S
    J Craniomaxillofac Surg; 2017 Apr; 45(4):570-578. PubMed ID: 28238559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.